Forendo Pharma66% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
NMD Pharma66% | - Similar verticals: Biotech, Health services, Pharma
- Similar business models: B2B
- At least one vc investor: Lundbeckfond Ventures, Novo Seeds
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Galecto Biotech66% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
BoneSupport56% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- At least one vc investor: Lundbeckfond Ventures
- Total raised in a similar range: 10M+ USD
|
MinervaX56% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Total raised in a similar range: 10M+ USD
|
AMRA55% | - Similar verticals: Health services
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Snipr Biome55% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Lundbeckfond Ventures
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Aprea Therapeutics54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
ITBMed54% | - Similar verticals: Biotech, Health services, Pharma
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Alvotech54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
OxThera54% | - Similar verticals: Biotech, Pharma
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Asarina Pharma54% | - Similar verticals: Health services, Pharma
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Mobidiag54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Oncoinvent54% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- Total raised in a similar range: 10M+ USD
- Minim one investor from outside Scandinavia: Yes
|
Merozyne Therapeutics46% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- At least one vc investor: Novo Seeds
|
Antag Therapeutics46% | - Similar verticals: Biotech, Health services
- Similar business models: B2B
- At least one vc investor: Novo Seeds
|
MetGen45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Sofinnova Partners
- Minim one investor from outside Scandinavia: Yes
|
Biosyntia45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds, Sofinnova Partners
- Minim one investor from outside Scandinavia: Yes
|
IO Biotech45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Lundbeckfond Ventures
- Total raised in a similar range: 10M+ USD
|
BioPhero45% | - Similar verticals: Biotech
- Similar business models: B2B
- At least one vc investor: Novo Seeds
- Minim one investor from outside Scandinavia: Yes
|